{"id":"W2890810711","doi":"10.1200/jco.2018.36.15_suppl.4090","title":"Outcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Internal medicine; Etiology; Sorafenib; Gastroenterology; Cabozantinib; Placebo; Incidence (geometry); Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00297734,0.001070161,0.001955697,0.0003772515,0.0003502619,0.0008649552,0.000433213,0.001119819,0.00214597],"category_scores_gemma":[0.002683841,0.0003748412,0.002548018,0.0004359666,0.0006206763,0.0007673267,0.0004834291,0.001996945,0.0002527411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006946099,"about_ca_system_score_gemma":0.0009332088,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005234984,"about_ca_topic_score_gemma":0.001248501,"domain_scores_codex":[0.9988931,0.0007133025,0.00007913559,0.0001276041,0.00007155546,0.0001153274],"domain_scores_gemma":[0.9984111,0.0004995512,0.0005549989,0.00009117376,0.00007140855,0.0003717571],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9826199,0.001196715,0.005496953,0.0002302249,0.001121422,0.00004248518,0.00002805275,0.0003607211,0.001026605,0.00004679091,0.0004629944,0.007367059],"study_design_scores_gemma":[0.7633561,0.1811894,0.04586294,0.0001080883,0.004046071,0.0001990867,0.00007275621,0.001944252,0.001293357,0.0005719091,0.00131095,0.00004501795],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926603,0.0044072,0.0002583759,0.0003750636,0.0001942156,0.0004831856,0.0007673387,0.00002270041,0.0008316044],"genre_scores_gemma":[0.9967817,0.0009481809,0.0002282034,0.0003502985,0.0001754903,0.0005608645,0.000615478,0.000004991723,0.0003347438],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00297734,"threshold_uncertainty_score":0.01574588,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.188982546222792,"score_gpt":0.4308723262109261,"score_spread":0.2418897799881342,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}